-
Circular of the center for drug examination of the State Food and Drug Administration on Issuing the technical requirements for pharmaceutical research(Trial) (No. 21, 2021)
Date of issue: 20210308In order to further guide enterprises to carry out drug R & D and accelerate the process of R & D and listing of overseas-listed and domestic unli
2021-03-10 vcc 0
-
Notice of the State Food and Drug Administration on the implementation of the provisions on the administration of cosmetic registration and filing mat
In order to implement the relevant provisions of the regulations on the supervision and administration of cosmetics and the measures for the administration of registration and filing of cosmetics, and
2021-03-10 vcc 6
-
The State Council Executive Meeting Passed the Regulation for Supervision of Cosmetics (Draft)
On January 3, 2020, Premier Li Keqiang presided over an executive meeting of the State Council. In the meeting, the Regulation for Supervision of Cosmetics (Draft) was approved. According to the requi
2021-01-20 vcc 0
-
NMPA Issued the Guidelines for Nomenclature for Common Names of Medical Devices
To further standardize the common names of medical devices and guide the compilation of nomenclature guidelines for various professional fields of medical devices, NMPA has organized the formulation o
2021-01-20 vcc 1
-
![NMPA Announces New and Revised Catalogues of Medical Devices Exempted from Clinical Trials]()
NMPA Announces New and Revised Catalogues of Medical Devices Exempted from Clinical Trials
As per the Opinions of the General Office of the CPC Central Committee and the General Office of the State Council on Deepening the Reform of Examination & Approval System to Encourage Innovation
2021-01-20 vcc 0
-
![COVID-19 vaccine reaches phase-2 trials in China]()
COVID-19 vaccine reaches phase-2 trials in China
BEIJING -- An inactivated COVID-19 vaccine candidate developed by the Institute of Medical Biology under the Chinese Academy of Medical Sciences has entered phase-2 clinical trials in China, the Scien
2020-06-24 vcc 1
-
![医療機器原材料の原薬等登録原簿の取扱いについて]()
-
![信頼性保証業務（GLP/GCP/GPSP）]()
信頼性保証業務（GLP/GCP/GPSP）
信頼性保証業務（GLP/GCP/GPSP） 信頼性保証業務とは、医薬品、医療機器又は再生医療等製品の承認申請又は再審査・再評価／使用成績評価申請された品目について、申請書に添付された資料（承認申請資料又は再審査･再評価／使用成績評価申請資料）が、厚生労働大臣の定める基準である医薬品、医療機器又は再生医療等製品GLP（安全性に関する非臨床試験の実施の基準に関する省令に示された基準）、医薬品、医療機器
2020-06-24 vcc 0